nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Dexamethasone—psoriatic arthritis	0.105	0.138	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—psoriatic arthritis	0.0845	0.111	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—psoriatic arthritis	0.0753	0.099	CbGbCtD
Zafirlukast—CYP2E1—Dexamethasone—psoriatic arthritis	0.075	0.0986	CbGbCtD
Zafirlukast—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0601	0.079	CbGbCtD
Zafirlukast—CYP2C8—Dexamethasone—psoriatic arthritis	0.056	0.0737	CbGbCtD
Zafirlukast—CYP2C19—Dexamethasone—psoriatic arthritis	0.047	0.0618	CbGbCtD
Zafirlukast—CYP3A4—Triamcinolone—psoriatic arthritis	0.0455	0.0599	CbGbCtD
Zafirlukast—CYP2C9—Dexamethasone—psoriatic arthritis	0.0391	0.0514	CbGbCtD
Zafirlukast—CYP3A4—Betamethasone—psoriatic arthritis	0.0391	0.0514	CbGbCtD
Zafirlukast—CYP3A4—Prednisolone—psoriatic arthritis	0.0386	0.0507	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—psoriatic arthritis	0.0364	0.0479	CbGbCtD
Zafirlukast—CYP2D6—Dexamethasone—psoriatic arthritis	0.0357	0.047	CbGbCtD
Zafirlukast—CYP3A4—Dexamethasone—psoriatic arthritis	0.0227	0.0299	CbGbCtD
Zafirlukast—Angioedema—Auranofin—psoriatic arthritis	0.00262	0.0109	CcSEcCtD
Zafirlukast—Leukocytoclastic vasculitis—Methotrexate—psoriatic arthritis	0.00259	0.0108	CcSEcCtD
Zafirlukast—Blister—Betamethasone—psoriatic arthritis	0.00242	0.0101	CcSEcCtD
Zafirlukast—Blister—Dexamethasone—psoriatic arthritis	0.00242	0.0101	CcSEcCtD
Zafirlukast—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00229	0.00957	CcSEcCtD
Zafirlukast—Vasculitis—Prednisolone—psoriatic arthritis	0.00214	0.00895	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Triamcinolone—psoriatic arthritis	0.00212	0.00884	CcSEcCtD
Zafirlukast—Dyspepsia—Auranofin—psoriatic arthritis	0.00206	0.00861	CcSEcCtD
Zafirlukast—Contusion—Betamethasone—psoriatic arthritis	0.002	0.00836	CcSEcCtD
Zafirlukast—Contusion—Dexamethasone—psoriatic arthritis	0.002	0.00836	CcSEcCtD
Zafirlukast—Vasculitis—Triamcinolone—psoriatic arthritis	0.00197	0.00823	CcSEcCtD
Zafirlukast—Vasculitis—Methylprednisolone—psoriatic arthritis	0.00197	0.00822	CcSEcCtD
Zafirlukast—Neuropathy—Prednisolone—psoriatic arthritis	0.00197	0.0082	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00192	0.008	CcSEcCtD
Zafirlukast—Urticaria—Auranofin—psoriatic arthritis	0.00186	0.00777	CcSEcCtD
Zafirlukast—Abdominal pain—Auranofin—psoriatic arthritis	0.00185	0.00773	CcSEcCtD
Zafirlukast—Haematemesis—Methotrexate—psoriatic arthritis	0.00183	0.00764	CcSEcCtD
Zafirlukast—Neuropathy—Triamcinolone—psoriatic arthritis	0.00181	0.00754	CcSEcCtD
Zafirlukast—Neuropathy—Methylprednisolone—psoriatic arthritis	0.0018	0.00753	CcSEcCtD
Zafirlukast—Vasculitis—Dexamethasone—psoriatic arthritis	0.00179	0.00747	CcSEcCtD
Zafirlukast—Vasculitis—Betamethasone—psoriatic arthritis	0.00179	0.00747	CcSEcCtD
Zafirlukast—Contusion—Prednisone—psoriatic arthritis	0.00174	0.00728	CcSEcCtD
Zafirlukast—Pruritus—Auranofin—psoriatic arthritis	0.00166	0.00692	CcSEcCtD
Zafirlukast—Injury—Prednisolone—psoriatic arthritis	0.00165	0.0069	CcSEcCtD
Zafirlukast—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.00165	0.00687	CcSEcCtD
Zafirlukast—Neuropathy—Dexamethasone—psoriatic arthritis	0.00164	0.00685	CcSEcCtD
Zafirlukast—Neuropathy—Betamethasone—psoriatic arthritis	0.00164	0.00685	CcSEcCtD
Zafirlukast—Diarrhoea—Auranofin—psoriatic arthritis	0.0016	0.00669	CcSEcCtD
Zafirlukast—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.00159	0.00664	CcSEcCtD
Zafirlukast—Vasculitis—Prednisone—psoriatic arthritis	0.00156	0.00651	CcSEcCtD
Zafirlukast—Injury—Triamcinolone—psoriatic arthritis	0.00152	0.00635	CcSEcCtD
Zafirlukast—Injury—Methylprednisolone—psoriatic arthritis	0.00152	0.00633	CcSEcCtD
Zafirlukast—Vomiting—Auranofin—psoriatic arthritis	0.00149	0.00622	CcSEcCtD
Zafirlukast—Rash—Auranofin—psoriatic arthritis	0.00148	0.00616	CcSEcCtD
Zafirlukast—Dermatitis—Auranofin—psoriatic arthritis	0.00148	0.00616	CcSEcCtD
Zafirlukast—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.00146	0.0061	CcSEcCtD
Zafirlukast—Neuropathy—Prednisone—psoriatic arthritis	0.00143	0.00596	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Methotrexate—psoriatic arthritis	0.0014	0.00584	CcSEcCtD
Zafirlukast—Nausea—Auranofin—psoriatic arthritis	0.00139	0.00581	CcSEcCtD
Zafirlukast—Injury—Dexamethasone—psoriatic arthritis	0.00138	0.00576	CcSEcCtD
Zafirlukast—Injury—Betamethasone—psoriatic arthritis	0.00138	0.00576	CcSEcCtD
Zafirlukast—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.00133	0.00554	CcSEcCtD
Zafirlukast—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.00133	0.00554	CcSEcCtD
Zafirlukast—Vasculitis—Methotrexate—psoriatic arthritis	0.0013	0.00544	CcSEcCtD
Zafirlukast—Injury—Prednisone—psoriatic arthritis	0.0012	0.00501	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00115	0.00479	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisolone—psoriatic arthritis	0.00106	0.00441	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00106	0.00441	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00105	0.0044	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisolone—psoriatic arthritis	0.00105	0.00439	CcSEcCtD
Zafirlukast—Hepatic failure—Methotrexate—psoriatic arthritis	0.00103	0.00429	CcSEcCtD
Zafirlukast—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000972	0.00406	CcSEcCtD
Zafirlukast—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000969	0.00405	CcSEcCtD
Zafirlukast—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000967	0.00404	CcSEcCtD
Zafirlukast—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000965	0.00403	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000958	0.004	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000958	0.004	CcSEcCtD
Zafirlukast—Neutropenia—Prednisone—psoriatic arthritis	0.000892	0.00373	CcSEcCtD
Zafirlukast—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000882	0.00368	CcSEcCtD
Zafirlukast—Haemoglobin—Betamethasone—psoriatic arthritis	0.000882	0.00368	CcSEcCtD
Zafirlukast—Haemorrhage—Betamethasone—psoriatic arthritis	0.000877	0.00366	CcSEcCtD
Zafirlukast—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000877	0.00366	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000852	0.00356	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000849	0.00354	CcSEcCtD
Zafirlukast—Angioedema—Prednisolone—psoriatic arthritis	0.000836	0.00349	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000834	0.00348	CcSEcCtD
Zafirlukast—Malaise—Prednisolone—psoriatic arthritis	0.000825	0.00344	CcSEcCtD
Zafirlukast—Back pain—Triamcinolone—psoriatic arthritis	0.000814	0.0034	CcSEcCtD
Zafirlukast—Eosinophilia—Methotrexate—psoriatic arthritis	0.00079	0.0033	CcSEcCtD
Zafirlukast—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000781	0.00326	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000779	0.00325	CcSEcCtD
Zafirlukast—Discomfort—Prednisolone—psoriatic arthritis	0.00077	0.00321	CcSEcCtD
Zafirlukast—Angioedema—Triamcinolone—psoriatic arthritis	0.000769	0.00321	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—psoriatic arthritis	0.000768	0.0032	CcSEcCtD
Zafirlukast—Angioedema—Methylprednisolone—psoriatic arthritis	0.000767	0.0032	CcSEcCtD
Zafirlukast—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000765	0.00319	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—psoriatic arthritis	0.000764	0.00319	CcSEcCtD
Zafirlukast—Malaise—Triamcinolone—psoriatic arthritis	0.000759	0.00317	CcSEcCtD
Zafirlukast—Malaise—Methylprednisolone—psoriatic arthritis	0.000757	0.00316	CcSEcCtD
Zafirlukast—Oedema—Prednisolone—psoriatic arthritis	0.000747	0.00312	CcSEcCtD
Zafirlukast—Neutropenia—Methotrexate—psoriatic arthritis	0.000746	0.00311	CcSEcCtD
Zafirlukast—Myalgia—Triamcinolone—psoriatic arthritis	0.000716	0.00299	CcSEcCtD
Zafirlukast—Myalgia—Methylprednisolone—psoriatic arthritis	0.000715	0.00298	CcSEcCtD
Zafirlukast—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000715	0.00298	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000708	0.00296	CcSEcCtD
Zafirlukast—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000708	0.00296	CcSEcCtD
Zafirlukast—Discomfort—Triamcinolone—psoriatic arthritis	0.000708	0.00295	CcSEcCtD
Zafirlukast—Discomfort—Methylprednisolone—psoriatic arthritis	0.000706	0.00295	CcSEcCtD
Zafirlukast—Angioedema—Dexamethasone—psoriatic arthritis	0.000698	0.00291	CcSEcCtD
Zafirlukast—Angioedema—Betamethasone—psoriatic arthritis	0.000698	0.00291	CcSEcCtD
Zafirlukast—Malaise—Betamethasone—psoriatic arthritis	0.000689	0.00287	CcSEcCtD
Zafirlukast—Malaise—Dexamethasone—psoriatic arthritis	0.000689	0.00287	CcSEcCtD
Zafirlukast—Oedema—Triamcinolone—psoriatic arthritis	0.000687	0.00287	CcSEcCtD
Zafirlukast—Infection—Triamcinolone—psoriatic arthritis	0.000682	0.00285	CcSEcCtD
Zafirlukast—Infection—Methylprednisolone—psoriatic arthritis	0.000681	0.00284	CcSEcCtD
Zafirlukast—Insomnia—Prednisolone—psoriatic arthritis	0.000675	0.00282	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000664	0.00277	CcSEcCtD
Zafirlukast—Myalgia—Betamethasone—psoriatic arthritis	0.00065	0.00271	CcSEcCtD
Zafirlukast—Myalgia—Dexamethasone—psoriatic arthritis	0.00065	0.00271	CcSEcCtD
Zafirlukast—Discomfort—Betamethasone—psoriatic arthritis	0.000642	0.00268	CcSEcCtD
Zafirlukast—Discomfort—Dexamethasone—psoriatic arthritis	0.000642	0.00268	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—psoriatic arthritis	0.000642	0.00268	CcSEcCtD
Zafirlukast—Pain—Prednisolone—psoriatic arthritis	0.000639	0.00267	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—psoriatic arthritis	0.000638	0.00266	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—psoriatic arthritis	0.000638	0.00266	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000626	0.00261	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000624	0.00261	CcSEcCtD
Zafirlukast—Oedema—Dexamethasone—psoriatic arthritis	0.000623	0.0026	CcSEcCtD
Zafirlukast—Oedema—Betamethasone—psoriatic arthritis	0.000623	0.0026	CcSEcCtD
Zafirlukast—Insomnia—Triamcinolone—psoriatic arthritis	0.000621	0.00259	CcSEcCtD
Zafirlukast—Insomnia—Methylprednisolone—psoriatic arthritis	0.00062	0.00259	CcSEcCtD
Zafirlukast—Infection—Betamethasone—psoriatic arthritis	0.000619	0.00258	CcSEcCtD
Zafirlukast—Infection—Dexamethasone—psoriatic arthritis	0.000619	0.00258	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000617	0.00258	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000615	0.00257	CcSEcCtD
Zafirlukast—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00061	0.00255	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00061	0.00255	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—psoriatic arthritis	0.000608	0.00254	CcSEcCtD
Zafirlukast—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000605	0.00252	CcSEcCtD
Zafirlukast—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000603	0.00252	CcSEcCtD
Zafirlukast—Malaise—Prednisone—psoriatic arthritis	0.0006	0.0025	CcSEcCtD
Zafirlukast—Urticaria—Prednisolone—psoriatic arthritis	0.000593	0.00248	CcSEcCtD
Zafirlukast—Fatigue—Triamcinolone—psoriatic arthritis	0.000592	0.00247	CcSEcCtD
Zafirlukast—Fatigue—Methylprednisolone—psoriatic arthritis	0.000591	0.00247	CcSEcCtD
Zafirlukast—Pain—Triamcinolone—psoriatic arthritis	0.000587	0.00245	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000568	0.00237	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000568	0.00237	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—psoriatic arthritis	0.000566	0.00236	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—psoriatic arthritis	0.000566	0.00236	CcSEcCtD
Zafirlukast—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000566	0.00236	CcSEcCtD
Zafirlukast—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000565	0.00236	CcSEcCtD
Zafirlukast—Insomnia—Betamethasone—psoriatic arthritis	0.000564	0.00235	CcSEcCtD
Zafirlukast—Insomnia—Dexamethasone—psoriatic arthritis	0.000564	0.00235	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00056	0.00234	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—psoriatic arthritis	0.000559	0.00233	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00055	0.0023	CcSEcCtD
Zafirlukast—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000549	0.00229	CcSEcCtD
Zafirlukast—Dyspepsia—Betamethasone—psoriatic arthritis	0.000549	0.00229	CcSEcCtD
Zafirlukast—Urticaria—Triamcinolone—psoriatic arthritis	0.000546	0.00228	CcSEcCtD
Zafirlukast—Urticaria—Methylprednisolone—psoriatic arthritis	0.000544	0.00227	CcSEcCtD
Zafirlukast—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000543	0.00227	CcSEcCtD
Zafirlukast—Oedema—Prednisone—psoriatic arthritis	0.000543	0.00227	CcSEcCtD
Zafirlukast—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000542	0.00226	CcSEcCtD
Zafirlukast—Infection—Prednisone—psoriatic arthritis	0.000539	0.00225	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000538	0.00225	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000538	0.00225	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—psoriatic arthritis	0.000538	0.00224	CcSEcCtD
Zafirlukast—Fatigue—Dexamethasone—psoriatic arthritis	0.000537	0.00224	CcSEcCtD
Zafirlukast—Fatigue—Betamethasone—psoriatic arthritis	0.000537	0.00224	CcSEcCtD
Zafirlukast—Pain—Betamethasone—psoriatic arthritis	0.000533	0.00222	CcSEcCtD
Zafirlukast—Pain—Dexamethasone—psoriatic arthritis	0.000533	0.00222	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000516	0.00215	CcSEcCtD
Zafirlukast—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000514	0.00214	CcSEcCtD
Zafirlukast—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000514	0.00214	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00051	0.00213	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00051	0.00213	CcSEcCtD
Zafirlukast—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000506	0.00211	CcSEcCtD
Zafirlukast—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000505	0.00211	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—psoriatic arthritis	0.000501	0.00209	CcSEcCtD
Zafirlukast—Urticaria—Betamethasone—psoriatic arthritis	0.000495	0.00207	CcSEcCtD
Zafirlukast—Urticaria—Dexamethasone—psoriatic arthritis	0.000495	0.00207	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000494	0.00206	CcSEcCtD
Zafirlukast—Dizziness—Prednisolone—psoriatic arthritis	0.000494	0.00206	CcSEcCtD
Zafirlukast—Asthenia—Triamcinolone—psoriatic arthritis	0.000493	0.00206	CcSEcCtD
Zafirlukast—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000493	0.00206	CcSEcCtD
Zafirlukast—Abdominal pain—Betamethasone—psoriatic arthritis	0.000493	0.00206	CcSEcCtD
Zafirlukast—Body temperature increased—Betamethasone—psoriatic arthritis	0.000493	0.00206	CcSEcCtD
Zafirlukast—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000493	0.00206	CcSEcCtD
Zafirlukast—Asthenia—Methylprednisolone—psoriatic arthritis	0.000492	0.00205	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—psoriatic arthritis	0.000491	0.00205	CcSEcCtD
Zafirlukast—Pruritus—Triamcinolone—psoriatic arthritis	0.000486	0.00203	CcSEcCtD
Zafirlukast—Pruritus—Methylprednisolone—psoriatic arthritis	0.000485	0.00202	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—psoriatic arthritis	0.000478	0.00199	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—psoriatic arthritis	0.000473	0.00197	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—psoriatic arthritis	0.000473	0.00197	CcSEcCtD
Zafirlukast—Rash—Prednisolone—psoriatic arthritis	0.000471	0.00197	CcSEcCtD
Zafirlukast—Dermatitis—Prednisolone—psoriatic arthritis	0.00047	0.00196	CcSEcCtD
Zafirlukast—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000469	0.00196	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—psoriatic arthritis	0.000468	0.00195	CcSEcCtD
Zafirlukast—Headache—Prednisolone—psoriatic arthritis	0.000468	0.00195	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—psoriatic arthritis	0.000467	0.00195	CcSEcCtD
Zafirlukast—Dizziness—Triamcinolone—psoriatic arthritis	0.000454	0.0019	CcSEcCtD
Zafirlukast—Dizziness—Methylprednisolone—psoriatic arthritis	0.000453	0.00189	CcSEcCtD
Zafirlukast—Infection—Methotrexate—psoriatic arthritis	0.000451	0.00188	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisone—psoriatic arthritis	0.000447	0.00187	CcSEcCtD
Zafirlukast—Asthenia—Dexamethasone—psoriatic arthritis	0.000447	0.00187	CcSEcCtD
Zafirlukast—Asthenia—Betamethasone—psoriatic arthritis	0.000447	0.00187	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000444	0.00185	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000444	0.00185	CcSEcCtD
Zafirlukast—Nausea—Prednisolone—psoriatic arthritis	0.000444	0.00185	CcSEcCtD
Zafirlukast—Pruritus—Dexamethasone—psoriatic arthritis	0.000441	0.00184	CcSEcCtD
Zafirlukast—Pruritus—Betamethasone—psoriatic arthritis	0.000441	0.00184	CcSEcCtD
Zafirlukast—Vomiting—Triamcinolone—psoriatic arthritis	0.000437	0.00182	CcSEcCtD
Zafirlukast—Vomiting—Methylprednisolone—psoriatic arthritis	0.000436	0.00182	CcSEcCtD
Zafirlukast—Rash—Triamcinolone—psoriatic arthritis	0.000433	0.00181	CcSEcCtD
Zafirlukast—Dermatitis—Triamcinolone—psoriatic arthritis	0.000433	0.00181	CcSEcCtD
Zafirlukast—Rash—Methylprednisolone—psoriatic arthritis	0.000432	0.0018	CcSEcCtD
Zafirlukast—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000432	0.0018	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—psoriatic arthritis	0.000431	0.0018	CcSEcCtD
Zafirlukast—Headache—Triamcinolone—psoriatic arthritis	0.00043	0.0018	CcSEcCtD
Zafirlukast—Headache—Methylprednisolone—psoriatic arthritis	0.000429	0.00179	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—psoriatic arthritis	0.000429	0.00179	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—psoriatic arthritis	0.000429	0.00179	CcSEcCtD
Zafirlukast—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000426	0.00178	CcSEcCtD
Zafirlukast—Diarrhoea—Betamethasone—psoriatic arthritis	0.000426	0.00178	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000413	0.00172	CcSEcCtD
Zafirlukast—Dizziness—Betamethasone—psoriatic arthritis	0.000412	0.00172	CcSEcCtD
Zafirlukast—Dizziness—Dexamethasone—psoriatic arthritis	0.000412	0.00172	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—psoriatic arthritis	0.00041	0.00171	CcSEcCtD
Zafirlukast—Nausea—Triamcinolone—psoriatic arthritis	0.000408	0.0017	CcSEcCtD
Zafirlukast—Nausea—Methylprednisolone—psoriatic arthritis	0.000407	0.0017	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisone—psoriatic arthritis	0.0004	0.00167	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—psoriatic arthritis	0.000399	0.00167	CcSEcCtD
Zafirlukast—Vomiting—Dexamethasone—psoriatic arthritis	0.000396	0.00165	CcSEcCtD
Zafirlukast—Vomiting—Betamethasone—psoriatic arthritis	0.000396	0.00165	CcSEcCtD
Zafirlukast—Rash—Betamethasone—psoriatic arthritis	0.000393	0.00164	CcSEcCtD
Zafirlukast—Rash—Dexamethasone—psoriatic arthritis	0.000393	0.00164	CcSEcCtD
Zafirlukast—Dermatitis—Dexamethasone—psoriatic arthritis	0.000393	0.00164	CcSEcCtD
Zafirlukast—Dermatitis—Betamethasone—psoriatic arthritis	0.000393	0.00164	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000392	0.00163	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—psoriatic arthritis	0.000391	0.00163	CcSEcCtD
Zafirlukast—Headache—Betamethasone—psoriatic arthritis	0.00039	0.00163	CcSEcCtD
Zafirlukast—Headache—Dexamethasone—psoriatic arthritis	0.00039	0.00163	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—psoriatic arthritis	0.000389	0.00163	CcSEcCtD
Zafirlukast—Pain—Methotrexate—psoriatic arthritis	0.000388	0.00162	CcSEcCtD
Zafirlukast—Pruritus—Prednisone—psoriatic arthritis	0.000384	0.0016	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000374	0.00156	CcSEcCtD
Zafirlukast—Diarrhoea—Prednisone—psoriatic arthritis	0.000371	0.00155	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000371	0.00155	CcSEcCtD
Zafirlukast—Nausea—Betamethasone—psoriatic arthritis	0.00037	0.00155	CcSEcCtD
Zafirlukast—Nausea—Dexamethasone—psoriatic arthritis	0.00037	0.00155	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—psoriatic arthritis	0.00036	0.0015	CcSEcCtD
Zafirlukast—Dizziness—Prednisone—psoriatic arthritis	0.000359	0.0015	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—psoriatic arthritis	0.000359	0.0015	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—psoriatic arthritis	0.000359	0.0015	CcSEcCtD
Zafirlukast—Vomiting—Prednisone—psoriatic arthritis	0.000345	0.00144	CcSEcCtD
Zafirlukast—Rash—Prednisone—psoriatic arthritis	0.000342	0.00143	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—psoriatic arthritis	0.000342	0.00143	CcSEcCtD
Zafirlukast—Headache—Prednisone—psoriatic arthritis	0.00034	0.00142	CcSEcCtD
Zafirlukast—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000334	0.00139	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—psoriatic arthritis	0.000325	0.00136	CcSEcCtD
Zafirlukast—Nausea—Prednisone—psoriatic arthritis	0.000322	0.00135	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—psoriatic arthritis	0.000321	0.00134	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—psoriatic arthritis	0.00031	0.0013	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—psoriatic arthritis	0.0003	0.00125	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—psoriatic arthritis	0.000288	0.0012	CcSEcCtD
Zafirlukast—Rash—Methotrexate—psoriatic arthritis	0.000286	0.00119	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—psoriatic arthritis	0.000286	0.00119	CcSEcCtD
Zafirlukast—Headache—Methotrexate—psoriatic arthritis	0.000284	0.00119	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—psoriatic arthritis	0.000269	0.00112	CcSEcCtD
